Literatur
-
1
Binder R J, Han D K, Srivastava P K.
CD91: a receptor for heat shock
protein gp96.
Nat Immunol.
2000;
1
(2)
151-5
-
2
Birkenmeier G, Kämpfer I, Kratzsch J, Schellenberger W.
Human leptin
forms complexes with alpha 2-macroglobulin which are recognized
by the alpha 2-macroglobulin receptor/low density lipoprotein
receptor-related protein.
Eur J Endocrinol.
1998;
139
(2)
224-30
-
3
Birkenmeier G, Müller R, Huse K, Forberg J, Gläser C, Hedrich H, Nicklisch S, Reichenbach A.
Human alpha2-macroglobulin:
genotype-phenotype relation.
Exp Neurol.
2003;
184
(1)
153-61
-
4
Birkenmeier G, Nicklisch S, Pockelt C, Mossie A, Steger V, Gläser C, Hauschildt S, Usbeck E, Huse K, Sack U, Bauer M, Schäfer A.
Polymyxin B-conjugated alpha 2-macroglobulin
as an adjunctive therapy to sepsis: Modes of action and impact on
lethality.
J Pharmacol Exp Ther.
2006;
318
(2)
762-71
-
5
Birkenmeier G, Stigbrand T.
Production of conformation-specific
monoclonal antibodies against alpha 2 macroglobulin and their use for
quantitation of total and transformed alpha 2 macroglobulin in human
blood.
J Immunol Methods.
1993;
162
(1)
59-67
-
6
Birkenmeier G.
Targetting the proteinase inhibitor and immune modulatory function
of human a2-macroglobulin.
Mod Asp Immunbiol.
2001;
2
32-36
-
7
Bock U, Kolac C, Borchard G, Koch K, Fuchs R, Streichhan P, Lehr C M.
Transport of proteolytic enzymes across Caco-2 cell monolayers.
Pharm Res.
1998;
15
(9)
1393-400
-
8
Cardillo M R, Petrangeli E, Perracchio L, Salvatori L, Ravenna L, Di Silverio F.
Transforming growth
factor-beta expression in prostate neoplasia.
Anal Quant
Cytol Histol.
2000;
22
(1)
1-10
-
9
Castell J V, Friedrich G, Kuhn C S, Poppe G E.
Intestinal absorption
of undegraded proteins in men: presence of bromelain in plasma after oral
intake.
Am J Physiol.
1997;
273
(1 Pt 1)
G139-46
-
10
Chu C T, Howard G C, Misra U K, Pizzo S V.
Alpha 2-macroglobulin:
a sensor for proteolysis.
Ann N Y Acad Sci.
1994;
737
291-307
-
11
Deane R, Zlokovic B V.
Role of the
blood-brain barrier in the pathogenesis of Alzheimer’s
disease.
Curr Alzheimer Res.
2007;
4
(2)
191-7
-
12
Desser L, Holomanova D, Zavadova E, Pavelka K, Mohr T, Herbacek I.
Oral therapy with proteolytic
enzymes decreases excessive TGF-beta levels in human blood.
Cancer
Chemother Pharmacol.
2001;
47 Suppl
S10-5
-
13
Lauer D, Müller R, Cott C, Otto A, Naumann M, Birkenmeier G.
Modulation of growth
factor binding properties of alpha2-macroglobulin by enzyme therapy.
Cancer Chemother Pharmacol.
2001;
47
Suppl
S4-9
-
14
Lauer D, Reichenbach A, Birkenmeier G.
Alpha 2-macroglobulin-mediated degradation of amyloid beta 1 – 42:
a mechanism to enhance amyloid beta catabolism.
Exp Neurol.
2001;
167
(2)
385-92
-
15
Li M O, Flavell R A.
TGF-beta:
a master of all T cell trades.
Cell.
2008;
134
(3)
392-404
-
16
Nalivaeva N N, Fisk L R, Belyaev N D, Turner A J.
Amyloid-degrading enzymes as therapeutic targets in Alzheimer’s
disease.
Curr Alzheimer Res.
2008;
5
(2)
212-24
-
17
Paczek L, Michalska W, Bartlomiejczyk I.
Trypsin, elastase, plasmin and MMP-9 activity in the serum during
the human ageing process.
Age Ageing.
2008;
37
(3)
318-23
-
18
Sinnreich O, Kratzsch J, Reichenbach A, Gläser C, Huse K, Birkenmeier G.
Plasma levels of transforming
growth factor-1beta and alpha2-macroglobulin before and after radical
prostatectomy: association to clinicopathological parameters.
Prostate.
2004;
61
(3)
201-8
-
19
Sottrup-Jensen L.
Alpha-macroglobulins: structure, shape, and mechanism of proteinase
complex formation.
J Biol Chem.
1989;
264
(20)
11 539-42
-
20
Waldron E, Heilig C, Schweitzer A, Nadella N, Jaeger S, Martin A M, Weggen S, Brix K, Pietrzik C U.
LRP1 modulates APP trafficking along early compartments of the
secretory pathway.
Neurobiol Dis.
2008;
31
(2)
188-97
-
21
Webb D J, Gonias S L.
A modified
human alpha 2-macroglobulin derivative that binds tumor necrosis
factor-alpha and interleukin-1 beta with high affinity in vitro
and reverses lipopolysaccharide toxicity in vivo in mice.
Lab Invest.
1998;
78
(8)
939-48
-
22
Wu S M, Patel D D, Pizzo S V.
Oxidized alpha2-macroglobulin (alpha2M)
differentially regulates receptor binding by cytokines/growth factors:
implications for tissue injury and repair mechanisms in inflammation.
J Immunol.
1998;
161
(8)
4356-65
Prof. Dr. Gerd Birkenmeier
Institut für Biochemie, Universität
Leipzig
Johannisallee 30
04103 Leipzig
Telefon: 0341/9722132
eMail: Gerd.Birkenmeier@medizin.uni-leipzig.de
